Andrew D. Krystal
University of California, San Francisco · Duke University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
6
all conditions, ClinicalTrials.gov
NIH grants tied to them
13
1 more share only the name and are not shown
Trial papers
57
PubMed author-name match
Trials
Studies that name Andrew D. Krystal as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:41 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06580041 · Precision Care for Major Depressive DisorderUniversity of California, San Francisco · enrolling by invitation · Major Depressive Disorder, Depression, Depressive Disorder, Major · principal investigator
- Ph4NCT05463861 · Lemborexant in Delayed Sleep Phase SyndromeStanford University · recruiting · Delayed Sleep Phase Syndrome
- Ph1NCT02218775 · FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 StudyAndrew Krystal · withdrawn · Anxiety Disorders
- Ph2NCT00901459 · A Controlled Laboratory Study of the Effects on Cue-Induced Craving in Dependent SmokersDuke University · completed · Nicotine Dependence · principal investigator
- Ph4NCT00465972 · The Treatment of Insomnia in Patients With HIV DiseaseDuke University · completed · HIV Infections, Insomnia
- Ph4NCT00365976 · Study of the Insomnia in Patients With Low Back PainDuke University · completed · Primary Insomnia
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Responsive Neurostimulation for Treatment Resistant DepressionUH3NS123310 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2023 to 2026 · $1,559,508 awarded in 2026Same name and institution; not confirmed by an ID
- IGF::OT::IGF TASK ORDER #001 - PERFORMANCE AREA A - ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT27120160000 · NIDA · DUKE UNIVERSITY · fiscal years 2016 to 2023 · $54,925 awarded in 2023Same name and institution; not confirmed by an ID
- Tissue-Specific Insulin Resistance in Obstructive Sleep Apnea: Role of HypoxiaR01DK117953 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2018 to 2023 · $803,867 awarded in 2023Same name and institution; not confirmed by an ID
- Deciphering principles of network dynamics underlying depression symptom severity from multi-day intracranial recordings in patients with major depressionR21MH124759 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2021 to 2022 · $201,875 awarded in 2022Same name and institution; not confirmed by an ID
- 2/3-Reducing Suicide Ideation Through Insomnia Treatment (REST-IT)R01MH095780 · NIMH · DUKE UNIVERSITY · fiscal years 2012 to 2016 · $48,679 awarded in 2016Same name and institution; not confirmed by an ID
- Transcranial Direct Current Stimulation (tDCS) as a Treatment for Acute FearR21MH106772 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2015 to 2016 · $254,191 awarded in 2016Same name and institution; not confirmed by an ID
- KOR Phase 1- FAST MAS (HHSN271201200006I) award-Duke Univ27120120000 · NIDA · DUKE UNIVERSITY · fiscal years 2014 to 2015 · $166,394 awarded in 2015Same name and institution; not confirmed by an ID
- 3/3-Improving Depression Outcome by Adding CBT for Insomnia to AntidepressantsR01MH079256 · NIMH · DUKE UNIVERSITY · fiscal years 2011 to 2012 · $178,331 awarded in 2012Same name and institution; not confirmed by an ID
- Biomarkers of the Response to CBT for Insomnia in Major DepressionR01HL096492 · NHLBI · DUKE UNIVERSITY · fiscal years 2009 to 2012 · $386,615 awarded in 2012Same name and institution; not confirmed by an ID
- Nocturnal Deterusor Overactivity In Overactive Bladder SyndromeR01DK087717 · NIDDK · DUKE UNIVERSITY · fiscal years 2010 to 2012 · $233,145 awarded in 2012Same name and institution; not confirmed by an ID
- Behavioral Insomnia Treatment in Chronic Fatigue SyndromeR21NR010539 · NINR · DUKE UNIVERSITY · fiscal years 2008 · $188,345 awarded in 2008Same name and institution; not confirmed by an ID
- OPTIMIZING ECT STIMULUS DOSING USING THE ICTAL EEGR29MH057532 · NIMH · DUKE UNIVERSITY · fiscal years 1998 to 2002 · $63,905 awarded in 2002Same name and institution; not confirmed by an ID
- IMPROVING ECT EFFECTIVENESS THROUGH ICTAL EEG ANALYSISK20MH001151 · NIMH · DUKE UNIVERSITY · fiscal years 1994 to 1998 · $150,036 awarded in 1998Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:41 UTC. The ranking covers the 200 most relevant of 57 PubMed records, and a shared surname and initials can bring in a namesake. All 57 on PubMed
- 310 citationsRCR 10.5
- NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes.Sleep · 2002265 citationsRCR 8.2
- 262 citationsRCR 10.8
- Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials.Biol Psychiatry · 2016228 citationsRCR 10.8
- Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial.Arch Intern Med · 2005206 citationsRCR 7.1
- 202 citationsRCR 11.4
- 160 citationsRCR 5.7
- 160 citationsRCR 9.0
- Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women: A Randomized Clinical Trial.JAMA Psychiatry · 2020134 citationsRCR 10.5
- 131 citationsRCR 4.9